August 16 - 18, 2024 - Hilton Rochester Mayo Clinic Area Hotel - Rochester, Minnesota

This course offers Live (in-person) and Livestream (virtual) attendance options

This conference provides NPs and PAs, from novice to seasoned providers, with cutting-edge information on caring for oncology and hematology patients. Learn with your fellow NPs and PAs about the active roles that advanced practice providers are playing in these constantly evolving fields. This is a great hematology and oncology educational event with opportunities to network with NP and PA colleagues. For our regional colleagues, it is an easy drive. Attend in person with options to view virtually live.

September 19 - 21, 2024 - Sheraton San Diego Hotel & Marina - San Diego, California

This course offers Live (in-person) and Livestream (virtual) attendance options

The Mayo Clinic Opioid Conference: Evidence, Clinical Considerations & Best Practice 2024 aims to highlight the shift in guidelines and public concern regarding the use of opioids in medical practice. This course provides the most up-to-date information regarding the appropriate indication for opioids in clinical practice. Topics cover the basics of opioid pharmacology and selection, evidence-based guidelines for opioid management, opioid tapering and legal considerations, as well as medical and interventional alternatives to opioids. In addition, the course covers a broad range of issues, including opioid use disorder and difficult patient conversations and guidelines to standardize the practice of opioid prescribing. This course includes lectures by experts in the field of pain medicine and opioid management as well as question and answer sessions. This continuing education activity satisfies the new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners. Learners should claim only the credit commensurate with the extent of their participation in the activity.

June 11, 2024 - 5:00 - 6:00 p.m. ET

This webinar series is presented via Livestream (virtual) only and presents in ET from Jacksonville, Florida

Management of chronic pain is complex, with primary care physicians and other non-pain management specialists often facing challenges in addressing complex pain. In particular, there are significant knowledge gaps regarding opioid management and nonpharmacologic management. This webinar series addresses these gaps with topics that focus on improving the safety and quality of treatment of patients with chronic pain in our community.

The use of buprenorphine in chronic pain management is growing, and misperceptions about its role and pharmacology are not uncommon. We are privileged to welcome our Palliative Medicine colleague to discuss the use of buprenorphine, including in the cancer pain population, particularly cancer survivorship.

October 8, 2024 at 5:00pm - 6:00pm ET

This webinar series is presented via Livestream (virtual) only and presents in ET from Jacksonville, Florida

Management of chronic pain is complex, with primary care physicians and other non-pain management specialists often facing challenges in addressing complex pain. In particular, there are significant knowledge gaps regarding opioid management and nonpharmacologic management. This webinar series addresses these gaps with topics that focus on improving the safety and quality of treatment of patients with chronic pain in our community.

Join us this month to learn about updates to best practices in opioid prescribing, including practical tips on safe and effective management of patients utilizing opioids for chronic pain. From identifying patients at risk for adverse effects due to opioids, recognizing substance use disorder, considering opioid alternatives, and outlining how to structure a safe and well-managed prescribing practice, we are pleased to outline the Mayo Clinic model of care with respect to opioid prescribing.

Available until September 1, 2024 - Podcast Online CME Education

Seth M. Kriha, PharmD identifies guideline recommended treatment to reduce LDL-C, evaluates landmark clinical trials for novel therapeutic agents indicated for treatment resistant hypercholesterolemia and develops a pharmacologic care plan for a patient with treatment resistant hypercholesterolemia.

Available until September 1, 2024 - Podcast Online CME Education

Jo Ann Leal, PharmD describes the key components of the drug supply chain and the impact of drug shortages, identifies common organizational strategies used to mitigate drug shortages and evaluates recent national efforts to stabilize the drug supply chain.